Bluebook
Diagnostics & Tools March 2020
2020 - March: Report on M&A and financing activity in the diagnostics and tools industry for CEOs and private equity professionals
Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
- QIAGEN N.V. to be acquired by Thermo Fisher Scientific
- Diploid was acquired by Invitae
- TeraRecon was acquired by SymphonyAI
- Marker Gene Technologies was acquired by Abcam
- Tempus Labs received $100 Million in Series G Financing